|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| C07K 16/18 | (2006.01) |
| (11) | Number of the document | 3672631 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18762749.2 |
| Date of filing the European patent application | 2018-08-22 | |
| (97) | Date of publication of the European application | 2020-07-01 |
| (45) | Date of publication and mention of the grant of the patent | 2023-03-29 |
| (46) | Date of publication of the claims translation | 2023-04-25 |
| (86) | Number | PCT/US2018/047508 |
| Date | 2018-08-22 |
| (87) | Number | WO 2019/040612 |
| Date | 2019-02-28 |
| (30) | Number | Date | Country code |
| 201762548583 P | 2017-08-22 | US |
| (72) |
LANTZ, Steven Andrew , US
GUPTA, Kapil , US
SULE, Shantanu , US
ZUNIC, Adnan , US
|
| (73) |
Biogen MA Inc. ,
225 Binney Street, Cambridge, MA 02142,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Farmacinės kompozicijos, kurių sudėtyje yra antikūnų prieš beta amiloidą |
| PHARMACEUTICAL COMPOSITIONS CONTAINING ANTI-BETA AMYLOID ANTIBODIES |
| Payment date | Validity (years) | Amount | |
| 2025-08-07 | 8 | 185.00 EUR |
| 2026-08-22 |